ACELYRIN, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Westlake BioPartners Fund II, L.P., was filed 11 May 2023.
ACELYRIN, Inc.: what insiders have been doing
ACELYRIN, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at ACELYRIN, Inc. has published a filing in the past twelve months. The most recent one dates from 23 May 2025.
Since 2023, the database holds 11 purchases and 7 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.
- 770,833 sharesCommon StockSEC:0001962918-25-000068:1
- 9,790,729 sharesCommon StockSEC:0001962918-25-000062:1
- 9,334,735 shares0Common Stock, par value $0.00001 per share ("Common Stock")SEC:0000902664-25-002533:0
- 14,675 sharesCommon StockSEC:0001962918-25-000056:0
- 50,000 sharesCommon StockSEC:0001962918-25-000058:0
- 89,526 sharesCommon StockSEC:0001962918-25-000068:0
- 121,789 sharesCommon StockSEC:0001962918-25-000060:0
- 2,999 sharesCommon StockSEC:0001962918-25-000052:0
- 121,587 sharesCommon StockSEC:0001962918-25-000064:0
- 15,000 sharesCommon StockSEC:0001962918-25-000054:0
- 60,000 sharesCommon StockSEC:0001962918-25-000062:0
- 11,039 shares@ US$2.1710.2% of flowCommon StockSEC:0001962918-25-000038:1
- 10,258 shares@ US$2.179.4% of flowCommon StockSEC:0001962918-25-000038:2
- 30,851 shares0Common StockSEC:0001962918-25-000038:0
- 17,986 shares@ US$2.74426.8% of flowCommon StockSEC:0001962918-25-000031:0
- 3,913 shares@ US$2.744100.0% of flowCommon StockSEC:0001962918-25-000029:0
- 3,211 shares@ US$2.744100.0% of flowCommon StockSEC:0001962918-25-000026:0
- 125,000 shares0Common StockSEC:0001962918-25-000009:0
- 125,000 shares0Common StockSEC:0001962918-25-000005:0
- 575,000 shares0Common StockSEC:0001962918-25-000007:0
- 1 shares@ US$6.860.0% of flowCommon StockSEC:0001962918-24-000099:0
- 10,298 shares@ US$4.47100.0% of flowCommon StockSEC:0001962918-24-000063:0
- 921 shares@ US$4.47100.0% of flowCommon StockSEC:0001962918-24-000060:0
- 10,230 shares@ US$4.4724.8% of flowCommon StockSEC:0001962918-24-000061:0
- 9,961 shares@ US$6.628325.2% of flowCommon StockSEC:0001962918-24-000036:0
25 of 66 declarations
About ACELYRIN, Inc.
ACELYRIN, Inc. is a company listed on the XNAS market, focused on developing innovative treatments for serious diseases.
Written on 25 June 2026 from the filings and market data available that day. Live figures are in the blocks above.
The weekly insider digest, free
One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.